Physician profile
Perry M Santos
NPI 1053418913
$3,379.94
in general payments reported to CMS, 2019-2025
11 companies · $261 in 2025
The $261 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.84 · 2020: $51.30 · 2021: $190 · 2022: $124 · 2023: $2,641 · 2024: $96.10 · 2025: $261.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,072 · Food and Beverage: $927.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,071.58 |
| Food and Beverage | $926.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,687.85 | 2022-2025 | Stealthstation S8 Platform, Fusion, Propel |
| Aerin Medical INC. | $187.09 | 2023 | |
| Glaxosmithkline, LLC. | $122.50 | 2024-2025 | |
| Intersect Ent, INC. | $92.88 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $91.30 | 2021 | |
| Alk-Abello, INC | $62.24 | 2021 | |
| Livanova USA, INC. | $36.69 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $36.09 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $27.20 | 2025 | Tezspire |
| Acclarent, INC | $20.89 | 2022 | |
| Stryker Corporation | $15.21 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Perry Santos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.